HIKAL LTD (India) holds 34 active US FDA Type II Drug Master Files and 6 inactive, has DMF or CEP filings on record for 35 active ingredients and is linked to 2 FDA-registered manufacturing sites. 1 FDA enforcement record is linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “HIKAL LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/hikal-ltd

Overview

HIKAL LTD is an active pharmaceutical ingredient (API) supplier with 34 active FDA Type II Drug Master Files, covering APIXABAN; BUPROPION HYDROBROMIDE (FORM II); BUPROPION HYDROBROMIDE (FORM-I); BUPROPION HYDROCHLORIDE USP; BUPROPION HYDROCHLORIDE USP [PROCESS-2]; BUTORPHANOL TARTRATE USP.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which HIKAL LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

HIKAL LTD holds 34 active (40 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • VONOPRAZAN FUMARATEActive2026-03-31
  • CARIPRAZINE HYDROCHLORIDEActive2026-03-30
  • EDOXABAN TOSYLATE MONOHYDRATEActive2024-09-30
  • DABIGATRAN ETEXILATE MESILATEActive2024-06-29
  • RIVAROXABAN USPActive2023-08-18
  • BUPROPION HYDROBROMIDE (FORM II)Active2023-05-29
  • BUPROPION HYDROBROMIDE (FORM-I)Active2023-03-24
  • DESVENLAFAXINE SUCCINATE USPActive2022-08-20
  • SITAGLIPTIN HYDROCHLORIDE (PROCESS B)Active2022-06-30
  • ERTUGLIFLOZIN L-PYROGLUTAMIC ACIDActive2020-05-01
  • SITAGLIPTIN PHOSPHATE ANHYDRATEActive2020-03-28
  • EMPAGLIFLOZINActive2018-09-12
  • DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE)Active2018-04-30
  • APIXABANActive2017-12-29
  • CELECOXIBActive2017-07-29
  • BUTORPHANOL TARTRATE USPActive2017-06-29
  • SITAGLIPTIN PHOSPHATE MONOHYDRATE (PROCESS-B)Active2017-03-17
  • VALACYCLOVIR HYDROCHLORIDE USPActive2016-03-29
  • LACOSAMIDE USPActive2016-02-25
  • VILDAGLIPTINActive2015-10-14
  • PREGABALIN (PROCESS-II)Active2015-08-12
  • PREGABALIN USPActive2014-09-19
  • BUPROPION HYDROCHLORIDE USP [PROCESS-2]Active2014-06-21
  • GABEPENTIN (A01804)Active2014-05-24
  • QUETIAPINE FUMARATE (PROCESS-B) USPActive2010-08-18
  • MEMANTINE HYDROCHLORIDE USPActive2010-02-22
  • VENLAFAXINE HYDROCHLORIDE USPActive2009-07-18
  • TRIPROLIDINE HYDROCHLORIDE USPActive2005-12-08
  • GEMFIBROZIL APIActive2005-09-15
  • ONDANSETRON USPActive2005-09-03
  • ONDANSETRON HYDROCHLORIDE USPActive2003-07-15
  • BUPROPION HYDROCHLORIDE USPActive2003-03-13
  • GABAPENTIN USPActive2002-07-24
  • PENTOXIFYLLINE USPActive1999-06-01
  • FAVIPIRAVIRInactive2021-03-27
  • DABIGATRAN ETEXILATE MESYLATEInactive2017-03-25
  • OLMESARTAN MEDOXOMIL USPInactive2016-03-22
  • VENLAFAXINE BASEInactive2014-02-18
  • DONEPEZIL HYDROCHLORIDE APIInactive2013-09-30
  • LEVETIRACETAM APIInactive2006-01-10

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to HIKAL LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

1 FDA enforcement record linked to this company.

  • warning_letter2025-08-20

    FDA Warning Letter (drug product)

For suppliers

Is this HIKAL LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.